Renascience Inc. (TYO:4889)
Japan · Delayed Price · Currency is JPY 1,725.00
+50.00 (2.99%)
At close: Mar 27, 2026
Renascience Market Cap
Renascience has a market cap or net worth of 23.31 billion as of March 27, 2026. Its market cap has increased by 37.06% in one year.
Market Cap
23.31B
Enterprise Value
20.89B
Revenue
107.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,725.00
Market Cap Chart
Since September 24, 2021, Renascience's market cap has increased from 10.13B to 23.31B, an increase of 130.02%. That is a compound annual growth rate of 20.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 23.31B | 26.76% |
| Dec 30, 2025 | 18.39B | 387.08% |
| Dec 30, 2024 | 3.78B | -31.57% |
| Dec 29, 2023 | 5.52B | 18.26% |
| Dec 30, 2022 | 4.67B | -46.27% |
| Dec 30, 2021 | 8.68B | -14.33% |
| Sep 24, 2021 | 10.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Stella Pharma | 29.98B |
| Japan Tissue Engineering | 28.14B |
| AnGes | 23.74B |
| RaQualia Pharma | 21.57B |
| StemRIM | 18.99B |
| ReproCELL | 17.33B |
| CanBas | 14.28B |
| Immuno-Biological Laboratories | 13.09B |